Magnetic Resonance Detects Changes from Chemotherapy
Author Information
Author(s): Ronen S M, DiStefano F, McCoy C L, Robertson D, Smith T A D, Al-Saffar N M, Titley J, Cunningham D C, Griffiths J R, Leach M O, Clarke P A
Primary Institution: Clinical Magnetic Resonance Research Group
Hypothesis
Can magnetic resonance spectroscopy detect metabolic changes associated with chemotherapy-induced apoptosis?
Conclusion
The study found that magnetic resonance spectroscopy can identify metabolic changes linked to apoptosis in cancer cells treated with chemotherapy.
Supporting Evidence
- Caspase activation was detected at 4 hours in L1210 cells treated with mechlorethamine.
- Magnetic resonance spectra showed a decrease in NTP and NAD and an increase in glycolytic intermediates.
- Doxorubicin treatment caused cells committed to apoptosis to detach, indicating a correlation with metabolic changes.
Takeaway
This study shows that special imaging can help us see how cancer cells change when they are treated with medicine that makes them die.
Methodology
The study monitored apoptosis in cancer cells using caspase activation and magnetic resonance spectroscopy to assess metabolic changes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website